Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NEW NORDIC HEALTHCARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   11.7% 7.8% 11.5% 2.5% 6.3% 4.1% 8.8% 8.6%   Credit score (0-100)   22 33 21 60 37 48 28 29   Credit rating   BB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   52,533 54,180 0 0 0 0 0 0   Gross profit   2,891 3,029 3,137 3,388 4,030 3,725 0.0 0.0   EBITDA   1,048 1,077 1,138 1,209 1,349 1,634 0.0 0.0   EBIT   1,048 1,077 1,138 1,209 1,115 1,399 0.0 0.0   Pre-tax profit (PTP)   1,039.0 1,068.5 1,128.0 1,189.0 1,114.7 1,393.8 0.0 0.0   Net earnings   799.9 828.2 871.2 914.6 849.8 1,079.4 0.0 0.0   Pre-tax profit without non-rec. items   1,039 1,068 1,128 1,189 1,115 1,394 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,069 2,697 3,568 4,482 3,832 4,912 4,787 4,787   Interest-bearing liabilities   3,032 6,860 6,111 1,287 6,461 4,109 0.0 0.0   Balance sheet total (assets)   12,872 15,084 18,470 12,588 18,307 16,127 4,787 4,787   Net Debt   2,971 6,658 6,105 1,269 6,450 3,658 -4,787 -4,787     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   52,533 54,180 0 0 0 0 0 0   Net sales growth   0.0% 3.1% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,891 3,029 3,137 3,388 4,030 3,725 0.0 0.0   Gross profit growth   -10.7% 4.8% 3.6% 8.0% 18.9% -7.6% -100.0% 0.0%   Employees   2 2 2 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 50.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,872 15,084 18,470 12,588 18,307 16,127 4,787 4,787   Balance sheet change%   7.5% 17.2% 22.4% -31.8% 45.4% -11.9% -70.3% 0.0%   Added value   1,048.0 1,077.4 1,137.8 1,208.6 1,114.6 1,633.9 0.0 0.0   Added value %   2.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 454 -219 -470 -235 0   Net sales trend   0.0 1.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   2.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   2.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   36.2% 35.6% 36.3% 35.7% 27.7% 37.6% 0.0% 0.0%   Net Earnings %   1.5% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   1.5% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.0% 2.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.4% 7.7% 6.8% 7.8% 7.2% 8.1% 0.0% 0.0%   ROI %   17.8% 13.8% 11.8% 15.7% 13.8% 14.2% 0.0% 0.0%   ROE %   21.8% 28.7% 27.8% 22.7% 20.4% 24.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   23.8% 17.9% 19.3% 35.6% 20.9% 30.5% 100.0% 100.0%   Relative indebtedness %   18.7% 22.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   18.5% 22.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   283.5% 618.0% 536.6% 105.0% 478.0% 223.9% 0.0% 0.0%   Gearing %   98.8% 254.4% 171.3% 28.7% 168.6% 83.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.4% 0.2% 0.2% 0.5% 0.1% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.2 1.2 1.4 1.2 1.4 0.0 0.0   Current Ratio   1.3 1.2 1.2 1.5 1.2 1.4 0.0 0.0   Cash and cash equivalent   61.4 201.9 5.8 17.8 10.4 451.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   85.1 94.3 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 63.2 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   24.5% 27.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,068.5 2,696.7 3,567.9 3,972.9 3,521.3 4,851.4 0.0 0.0   Net working capital %   5.8% 5.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   26,267 27,090 0 0 0 0 0 0   Added value / employee   524 539 569 403 372 545 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   524 539 569 403 450 545 0 0   EBIT / employee   524 539 569 403 372 466 0 0   Net earnings / employee   400 414 436 305 283 360 0 0